Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Published in: Calcified Tissue International 3/2015

01-09-2015 | Review

Do Non-collagenous Proteins Affect Skeletal Mechanical Properties?

Authors: Stacyann Morgan, Atharva A. Poundarik, Deepak Vashishth

Published in: Calcified Tissue International | Issue 3/2015

Login to get access

Abstract

The remarkable mechanical behavior of bone is attributed to its complex nanocomposite structure that, in addition to mineral and collagen, comprises a variety of non-collagenous matrix proteins or NCPs. Traditionally, NCPs have been studied as signaling molecules in biological processes including bone formation, resorption, and turnover. Limited attention has been given to their role in determining the mechanical properties of bone. Recent studies have highlighted that NCPs can indeed be lost or modified with aging, diseases, and drug therapies. Homozygous and heterozygous mice models of key NCP provide a useful approach to determine the impact of NCPs on bone morphology as well as matrix quality, and to carry out detailed mechanical analysis for elucidating the pathway by which NCPs can affect the mechanical properties of bone. In this article, we present a systematic analysis of a large cohort of NCPs on bone’s structural and material hierarchy, and identify three principal pathways by which they determine bone’s mechanical properties. These pathways include alterations of bone morphological parameters crucial for bone’s structural competency, bone quality changes in key matrix parameters (mineral and collagen), and a direct role as load-bearing structural proteins.
Literature
1.
Mccreadie BR, Goldstein SA (2000) Biomechanics of fracture: is bone mineral density sufficient to assess risk? J Bone Miner Res 15(12):2305–2308PubMedCrossRef
2.
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259PubMedCentralPubMedCrossRef
3.
Bouxsein ML (2003) Bone quality: where do we go from here? Osteoporos Int 14(5):118–127CrossRef
4.
Paschalis EP, Shane E, Lyritis G, Skarantavos G, Mendelsohn R, Boskey AL (2004) Bone fragility and collagen cross-links. J Bone Miner Res 19(12):2000–2004PubMedCentralPubMedCrossRef
5.
6.
Ferris BD, Klenerman L, Dodds RA, Bitensky L, Chayen J (1987) Altered organization of non-collagenous bone matrix in osteoporosis. Bone 8(5):285–288PubMedCrossRef
7.
Grynpas MD, Tupy JH, Sodek J (1994) The distribution of soluble, mineral-bound, and matrix-bound proteins in osteoporotic and normal bones. Bone 15(5):505–513PubMedCrossRef
8.
Ducy P, Desbois C, Boyce B, Pinero G et al (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382(6590):448–452PubMedCrossRef
9.
10.
Glowacki J, Rey C, Glimcher MJ, Cox KA, Lian J (1991) A role for osteocalcin in osteoclast differentiation. J Cell Biochem 45(3):292–302PubMedCrossRef
11.
Rittling SR, Matsumoto HN, Mckee MD et al (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13(7):1101–1111PubMedCrossRef
12.
Romberg RW, Werness PG, Riggs BL, Mann KG (1986) Inhibition of hydroxyapatite-crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 25(5):1176–1180PubMedCrossRef
13.
14.
Boskey AL (1989) Noncollagenous matrix proteins and their role in mineralization. Bone Miner. 6(2):111–123PubMedCrossRef
15.
Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G (1998) Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23(3):187–196PubMedCrossRef
16.
Ameye L, Young MF (2002) Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12(9):107R–116RPubMedCrossRef
17.
Nikel O, Laurencin D, McCallum SA, Gundberg CM, Vashishth D (2013) NMR investigation of the role of osteocalcin and osteopontin at the organic-inorganic interface in bone. Langmuir 29(45):13873–13882PubMedCentralPubMedCrossRef
18.
Boskey AL, Spevak L, Paschalis E, Doty SB, McKee MD (2002) Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 71(2):145–154PubMedCrossRef
19.
Kavukcuoglu NB, Denhardt DT, Guzelsu N, Mann AB (2007) Osteopontin deficiency and aging on nanomechanics of mouse bone. J Biomed Mater Res Part A 83(1):136–144CrossRef
20.
Hansma PK, Fantner GE, Kindt JH et al (2005) Sacrificial bonds in the interfibrillar matrix of bone. J Musculoskelet Neuronal Interact 5(4):313PubMed
21.
Gupta HS, Wagermaier W, Zickler GA et al (2005) Nanoscale deformation mechanisms in bone. Nano Lett 5(10):2108–2111PubMedCrossRef
22.
23.
Garnero P, Delmas PD (2004) Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact 4(1):50PubMed
24.
Seibel MJ (2005) Biochemical markers of bone turnover part I: biochemistry and variability. Clin Biochemist 26(4):97
25.
Ammann P, Rizzoli R, Meyer JM, Bonjour JP (1996) Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats. Osteoporos Int 6(3):219–227PubMedCrossRef
26.
Crabtree N, Loveridge N, Parker M, Rushton N et al (2001) Intracapsular hip fracture and the region-specific loss of cortical bone: analysis by peripheral quantitative computed tomography. J Bone Miner Res 16(7):1318–1328PubMedCrossRef
27.
28.
Van der Meulen MCH, Jepsen KJ, Mikić B (2001) Understanding bone strength: size isn’t everything. Bone 29(2):101–104PubMedCrossRef
29.
Wolf G (1996) Function of the bone protein osteocalcin: definitive evidence. Nutr Rev 54(10):332–333PubMedCrossRef
30.
Ingram RT, Clarke BL, Fisher LW, Fitzpatrick LA (1993) Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res 8(9):1019–1029PubMedCrossRef
31.
Xu T, Bianco P, Fisher LW, Longenecker G et al (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20(1):78–82PubMedCrossRef
32.
Corsi A, Xu T, Chen XD, Boyde A et al (2002) Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 17(7):1180–1189PubMedCrossRef
33.
Arteaga-Solis E, Sui-Arteaga L, Kim M, Schaffler MB et al (2011) Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. Matrix Biol 30(3):188–194PubMedCentralPubMedCrossRef
34.
Termine JD, Kleinman HK, Whitson SW, Conn KM et al (1981) Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26(1):99–105PubMedCrossRef
35.
36.
Rios H, Koushik SV, Wang H, Wang J et al (2005) Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 25(24):11131–11144PubMedCentralPubMedCrossRef
37.
Bonnet N, Standley KN, Bianchi EN, Stadelmann V et al (2009) The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity. J Biol Chem 284(51):35939–35950PubMedCentralPubMedCrossRef
38.
Gowen LC, Petersen DN, Mansolf AL, Qi H et al (2003) Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278(3):1998–2007PubMedCrossRef
39.
Malaval L, Wade-Guéye NM, Boudiffa M, Fei J et al (2008) Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205(5):1145–1153PubMedCentralPubMedCrossRef
40.
41.
Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE (2007) Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res 22(2):286–297PubMedCrossRef
42.
43.
Delany AM, Hankenson KD (2009) Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal 3(3–4):227–238PubMedCentralPubMedCrossRef
44.
Bonnet N, Gineyts E, Ammann P, Conway SJ, Garnero P, Ferrari S (2013) Periostin deficiency increases bone damage and impairs injury response to fatigue loading in adult mice. PLoS One 8(10):e78347PubMedCentralPubMedCrossRef
45.
Currey JD (1984) Effects of differences in mineralization on the mechanical properties of bone. Philos Trans R Soc Lond B 304(1121):509–518CrossRef
46.
Schaffler MB, Burr DB (1988) Stiffness of compact bone: effects of porosity and density. J Biomech 21(1):13–16PubMedCrossRef
47.
Viguet-Carrin S, Garnero P, Delmas PD (2006) The role of collagen in bone strength. Osteoporos Int 17(3):319–336PubMedCrossRef
48.
Vashishth D (2007) The role of the collagen matrix in skeletal fragility. Current Osteoporos Rep 5(2):62–66CrossRef
49.
Yoshitake H, Rittling SR, Denhardt DT, Noda M (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci 96(14):8156–8160PubMedCentralPubMedCrossRef
50.
Rodriguez DE, Thula-Mata T, Toro EJ, Yeh YW, Holt C, Holliday LS, Gower LB (2014) Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts. Acta Biomater 10(1):494–507PubMedCrossRef
51.
Boskey A (2003) Bone mineral crystal size. Osteoporosis international 14(5):16–21
52.
Augat P, Schorlemmer S (2006) The role of cortical bone and its microstructure in bone strength. Age Ageing 35(suppl 2):ii27–ii31PubMed
53.
Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N (1976) Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci 73(5):1447–1451PubMedCentralPubMedCrossRef
54.
Kavukcuoglu NB, Patterson-Buckendahl P, Mann AB (2009) Effect of osteocalcin deficiency on the nanomechanics and chemistry of mouse bones. J Mech Behav Biomed Mater 2(4):348–354PubMedCrossRef
55.
Jepsen KJ, Davy DT, Krzypow DJ (1999) The role of the lamellar interface during torsional yielding of human cortical bone. J Biomech 32(3):303–310PubMedCrossRef
56.
Vashishth D (2004) Rising crack-growth-resistance behavior in cortical bone: implications for toughness measurements. J Biomech 37(6):943–946PubMedCrossRef
57.
Burstein AH, Zika JM, Heiple KG, Klein L (1975) Contribution of collagen and mineral to the elastic-plastic properties of bone. J Bone Joint Surg 57(7):956–961PubMed
58.
Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28(2):195–201PubMedCrossRef
59.
Kavukcuoglu NB, Arteaga-Solis E, Lee-Arteaga S, Ramirez F, Mann AB (2007) Nanomechanics and Raman spectroscopy of fibrillin 2 knock-out mouse bones. J Mater Sci 42(21):8788–8794CrossRef
60.
Vogel KG, Paulsson M, Heinegard D (1984) Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223:587–597PubMedCentralPubMed
61.
Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136(3):729–743PubMedCentralPubMedCrossRef
62.
Hoshi K, Kemmotsu S, Takeuchi Y, Amizuka N, Ozawa H (1999) The primary calcification in bones follows removal of decorin and fusion of collagen fibrils. J Bone Miner Res 14(2):273–280PubMedCrossRef
63.
Sugars RV, Milan AM, Brown JO, Waddington RJ et al (2002) Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth. Connect Tissue Res 44:189–195CrossRef
64.
Boskey AL, Spevak L, Doty SB, Rosenberg L (1997) Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int 61(4):298–305PubMedCrossRef
65.
66.
Termine JD, Kleinman HK, Whitson SW et al (1981) Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26(1):99–105PubMedCrossRef
67.
Boskey AL, Moore DJ, Amling M, Canalis E, Delany AM (2003) Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res 18(6):1005–1011PubMedCrossRef
68.
Oxlund H, Barckman M, Ortoft G, Andreassen TT (1995) Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 17(4):S365–S371CrossRef
69.
Vashishth D (2005) Collagen glycation and its role in fracture properties of bone. J Musculoskelet Neuronal Interact 5(4):316PubMed
70.
Landis WJ, Hodgens KJ, Song MJ, Arena J et al (1996) Mineralization of collagen may occur on fibril surfaces: evidence from conventional and high-voltage electron microscopy and three-dimensional imaging. J Struct Biol 117(1):24–35PubMedCrossRef
71.
Sasaki N, Nakayama Y, Yoshikawa M, Enyo A (1993) Stress relaxation function of bone and bone collagen. J Biomech 26(12):1369–1376PubMedCrossRef
72.
Tai K, Dao M, Suresh S, Palazoglu A, Ortiz C (2007) Nanoscale heterogeneity promotes energy dissipation in bone. Nat Mater 6(6):454–462PubMedCrossRef
73.
Gao H, Ji B, Jäger IL, Arzt E, Fratzl P (2003) Materials become insensitive to flaws at nanoscale: lessons from nature. Proc Natl Acad Sci 100(10):5597–5600PubMedCentralPubMedCrossRef
74.
Jackson AP, Vincent JFV, Turner RM (1988) The mechanical design of nacre. Proc R Soc Lond B Biol Sci 234(1277):415–440CrossRef
75.
Barthelat F, Rabiei R (2011) Toughness amplification in natural composites. J Mech Phys Solids 59(4):829–840CrossRef
76.
Maruyama N, Shibata Y, Mochizuki A, Yamada A et al (2015) Bone micro-fragility caused by the mimetic aging processes in α-klotho deficient mice: in situ nanoindentation assessment of dilatational bands. Biomaterials 47:62–71PubMedCrossRef
77.
Ritter NM, Farach-Carson MC, Butler WT (1992) Evidence for the formation of a complex between osteopontin and osteocalcin. J Bone Miner Res 7(8):877–885PubMedCrossRef
78.
Thompson JB, Kindt JH, Drake B, Hansma HG et al (2001) Bone indentation recovery time correlates with bond reforming time. Nature 414(6865):773–776PubMedCrossRef
79.
Hassenkam T, Fantner GE, Cutroni JA, Weaver JC et al (2004) High-resolution AFM imaging of intact and fractured trabecular bone. Bone 35(1):4–10PubMedCrossRef
80.
Fantner GE, Hassenkam T, Kindt JH et al (2005) Sacrificial bonds and hidden length dissipate energy as mineralized fibrils separate during bone fracture. Nat Mater 4(8):612–616PubMedCrossRef
81.
Fantner GE, Adams J, Turner P, Thurner PJ et al (2007) Nanoscale ion mediated networks in bone: osteopontin can repeatedly dissipate large amounts of energy. Nano Lett 7(8):2491–2498PubMedCrossRef
82.
Diab T, Vashishth D (2005) Effects of damage morphology on cortical bone fragility. Bone 37(1):96–102PubMedCrossRef
83.
84.
Burr DB, Turner CH, Naick P, Forwood MR et al (1998) Does microdamage accumulation affect the mechanical properties of bone? J Biomech 31(4):337–345PubMedCrossRef
Metadata
Title
Do Non-collagenous Proteins Affect Skeletal Mechanical Properties?
Authors
Stacyann Morgan
Atharva A. Poundarik
Deepak Vashishth
Publication date
01-09-2015
Publisher
Springer US
Published in
Calcified Tissue International / Issue 3/2015
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-0016-3

Other articles of this Issue 3/2015

Calcified Tissue International 3/2015 Go to the issue

Review

Bone’s Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment

Review

The Mineral–Collagen Interface in Bone

Original Research

The Role of Collagen Organization on the Properties of Bone

Review

Bone Material Properties and Skeletal Fragility

Review

Fragility of Bone Material Controlled by Internal Interfaces

Erratum

Erratum to: The Role of Collagen Organization on the Properties of Bone
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits